Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Seres Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −2 vs. Q4 2025
- Shares held
- 2.31M
- +189.1K (+8.9%) vs. Q4 2025
- Total value
- $20.5M
- −$11.1M (−35.1%) vs. Q4 2025
- New holders
- 5
- 10 more added
- Sold out
- 7
- 8 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $17.9M |
| Q1 2026 | 33 | $20.5M |
| Q4 2025 | 36 | $36.4M |
| Q3 2025 | 32 | $40.9M |
| Q2 2025 | 33 | $25.4M |
| Q1 2025 | 63 | $43.1M |
| Q4 2024 | 69 | $52.5M |
| Q3 2024 | 77 | $60.1M |
| Q2 2024 | 93 | $50.0M |
| Q1 2024 | 99 | $66.3M |
| Q4 2023 | 103 | $125.4M |
| Q3 2023 | 134 | $255.6M |
| Q2 2023 | 138 | $538.1M |
| Q1 2023 | 123 | $593.9M |
| Q4 2022 | 124 | $588.2M |
| Q3 2022 | 120 | $671.6M |
| Q2 2022 | 123 | $312.7M |
| Q1 2022 | 131 | $537.2M |
| Q4 2021 | 148 | $642.8M |
| Q3 2021 | 133 | $555.1M |
| Q2 2021 | 147 | $1.93B |
| Q1 2021 | 154 | $1.85B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SRS Capital Advisors, Inc. | 6 | $18 | 0.00% | +4+200.0% | Added |
| Allworth Financial LP | 4 | $36 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8 | $70 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 8 | $71 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10 | $89 | 0.00% | −250−96.2% | Reduced |
| Royal Bank of Canada | 107 | $1.00K | 0.00% | +98+1,088.9% | Added |
| UMA Financial Services, Inc. | 142 | $1.26K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 211 | $1.87K | 0.00% | −562−72.7% | Reduced |
| Tower Research Capital LLC (TRC) | 794 | $7.04K | 0.00% | +794 | New |
| Group One Trading, L.P. | 824 | $7.31K | 0.00% | +824 | New |
| Rachor Investment Advisory Services, LLC | 1,477 | $13.1K | 0.01% | 00.0% | Unchanged |
| FMR LLC | 1,752 | $15.5K | 0.00% | +12+0.7% | Added |
| Vanguard Global Advisers, LLC | 1,975 | $17.5K | 0.00% | +1,975 | New |
| Simplex Trading, LLC | 3,070 | $27.2K | 0.00% | +1,838+149.2% | Added |
| SBI Securities Co., Ltd. | 3,482 | $30.9K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6,507 | $57.7K | 0.00% | −925−12.4% | Reduced |
| UBS Group AG | 7,030 | $62.4K | 0.00% | +2,804+66.4% | Added |
| Invesco Ltd. | 14,547 | $129.0K | 0.00% | +187+1.3% | Added |
| Northern Trust Corp | 14,765 | $131.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 18,794 | $166.7K | 0.00% | −6,955−27.0% | Reduced |
| Morgan Stanley | 21,700 | $192.5K | 0.00% | −3,426−13.6% | Reduced |
| Lion Point Capital, LP | 31,570 | $280.0K | 1.67% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 31,630 | $280.6K | 0.00% | +261+0.8% | Added |
| State Street Corp | 33,901 | $300.7K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 39,643 | $351.6K | 0.00% | +39,643 | New |
| American Century Companies Inc | 62,316 | $552.7K | 0.00% | +46,045+283.0% | Added |
| Geode Capital Management, LLC | 74,835 | $664.1K | 0.00% | −11,307−13.1% | Reduced |
| BlackRock, Inc. | 102,026 | $905.0K | 0.00% | −1,595−1.5% | Reduced |
| Susquehanna International Group, LLP | 105,339 | $934.4K | 0.00% | −74,590−41.5% | Reduced |
| Vontobel Holding Ltd. | 138,468 | $1.23M | 0.00% | +35,234+34.1% | Added |
| Marshall Wace, LLP | 139,539 | $1.24M | 0.00% | +19,362+16.1% | Added |
| Vanguard Capital Management LLC | 294,143 | $2.61M | 0.00% | +294,143 | New |
| Flagship Pioneering Inc. | 1,155,850 | $10.3M | 0.88% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −52,314−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −31,418−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −29,097−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −14,400−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −14,340−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,737−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −195−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |